38 Acquisition International - Global Excellence 2021 Acquisition International - Issue 11 2021 39 Changing the Game in Tissue Viability Assessment For three years running, 2019-2021, Canadian-based Medtech firm Kent Imaging Inc. has been recognized by AI Global Media as the most innovative medical imaging technology developer in Canada. A market leader in light-based tissue assessment devices, Kent Imaging is helping physicians drive better outcomes in wound care, limb preservation and surgery, with its diagnostic imaging technology that assesses tissue oxygenation. We profiled the company to understand more about their continued development and deserved success. Sep21042 sing multiple wavelengths of near-infrared (NIR) light, SnapshotNIR, Kent’s flagship product, non-invasively measures relative amounts of oxygenated and deoxygenated hemoglobin in the microcirculation of tissue where oxygen exchange is happening. With the click of a button, users are provided with a near-instant tissue oxygen saturation map. Kent Imaging has seized upon an opportunity to deliver an innovative, cost-effective solution in an area where rapid understanding of tissue viability, and the ability to track and document wound healing progression, can have a huge impact on healthcare costs, treatment decisions, and patient outcomes. SnapshotNIR is a portable and easy-to-use imaging device. It is completely non-invasive eliminating the need for patient contact, leads, or injected dyes required by other technologies. The greatest differentiator is the ability to measure and report on the oxygen status of the microvascular network, where oxygen exchange occurs. Competitive products to assess tissue viability tend to be cumbersome, take considerable time to capture a study, and measure only macrovascular flow. The presence of blood, or even oxygenated blood, in the large vessels does not necessarily equate to oxygenation in tissues. Kent’s SnapshotNIR offers users rapid, actionable information that can impact decision-making and guide the treatment pathway at all stages of care. A core value at Kent Imaging is a pioneering spirit – the drive to push boundaries to deliver significant advances. Knowing that they are developing technologies that can make a big difference in the market for better outcomes inspires and pushes the team. Kent also attributes its success to the fact that they understand and appreciate the value of the relationships with their employees, partners, and customers. Being respectful and responsive to feedback will continue to make their product offerings stronger in the markets they serve. When it comes to hiring the best staff, Kent Imaging genuinely believes that every employee contributes directly to the growth and success of the company. They are committed to recruiting and selecting individuals who are experienced, ambitious, and confident in bringing forward new ways of looking at things. Kent Imaging seeks out individuals who exhibit their core values, especially teamwork and a pioneering spirit. Employing a mix of talented individuals, staff range from engineers, software developers and clinical research specialists to industry-seasoned sales and marketing professionals who thrive as a team to reach a common goal. To strengthen the mix, U Kent’s CEO has also been firmly entrenched in the high-tech world of imaging for nearly three decades. Looking to the future, Kent Imaging’s goal in the coming years is to continue to firmly establish itself as the market leader in tissue assessment. Expanding its reach across North America, Kent is looking to permeate the global markets to provide invaluable insight into tissue health into the hands of clinicians who are striving to deliver optimal care. And that delivers on the company mission: reducing complications and improving outcomes for patients. Company: Kent Imaging Inc. Contact: Sandra Jenks Website: kentimaging.com Pierre Lemire, CEO Kent Imaging
RkJQdWJsaXNoZXIy NTY1MjI4